by | Jan 22, 2026 | Diamond, Michael, Fremont, Daved, Hui, Sean, Li, Pengfei
— Published date: 1/14/2026
Value Proposition: Entry receptors that bind directly to TBEV, promoting virus attachment to treat TBEV and other viruses.
Technology Description
Researchers at Washington University in St. Louis have developed LRP8 soluble decoy receptors (minimal domains-Fc fusion …
by | Jan 22, 2026 | Chong, Zhenlu, Diamond, Michael, Fremont, Daved, Hui, Sean
— Published date: 1/14/2026
Value Proposition: First antiviral treatment that uses soluble receptors to treat yellow fever.
Technology Description
Researchers at Washington University in St. Louis have developed new soluble receptor decoy Fc-fusion protein inhibitors for the treatment of yellow f…
